A practical reference on visceral adipose tissue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-01-08 and is reviewed periodically as new material appears.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
| Property | Value | Notes |
|---|---|---|
| Primary marker | Insulin-like growth factor 1 | Slow-changing integrated indicator of axis activity |
| Secondary marker | Growth hormone | Pulsatile; requires repeated or timed sampling |
| Typical analytical method | Immunoassay | Antibody-based quantification in serum |
| Common sample matrix | Serum | Collected under standardized conditions |
| Key interpretation factor | Age-stratified reference ranges | Baseline marker concentrations shift with age |
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
A university reports on the first study (25 Oct) of the new privacy-intrusion Web tracking technique of "UID smuggling" by the ad industry, which finds it to be prevalent and largely not mitigated by latest protection tools – such as Firefox's tracking protection and uBlock Origin – and contributes to countermeasures. 15 December Astronomers find that a pair of exoplanets orbiting the red dwarf star Kepler-138 are likely to be water worlds. News reports about the development (22 Oct) in China of an edible, plant-based ink derived from food waste, which could be used in 3D printing of scaffolds to reduce the cost of cultured meat. Promising results of therapeutic candidates are reported: phase 2-trialed talquetamab against multiple myeloma (10&15 Dec), a phase 1-trialed HIV vaccine (2 Dec), mice-tested Pillar[6]MaxQ against meth and fentanyl drug overdoses (15 Dec), first approval of a trialed honeybee vaccine against American foulbrood (29 Dec), a mice-tested triple combination therapy against pancreatic cancer of immunotherapy medications undergoing trials as monotherapies (30 Dec). 19 December – A new world record solar cell efficiency for a silicon-perovskite tandem solar cell is achieved, with scientists in Germany converting 32.5% of sunlight into electrical energy. 20 December – OpenAI releases Point-E, a machine learning system that can generate 3D models from text prompts (text-to-3D), similar to previously released GET3D and Magic3D by Nvidia and DreamFusion by Google.
=== Magnetic plasmon resonance === Recently, there has been an interest in magnetic surface plasmons. These require materials with large negative magnetic permeability, a property that has only recently been made available with the construction of metamaterials.
In contrast, on the same day Medtronic's capitalization was listed on Bloomberg at just over $130 billion (or €115 billion). Medtronic's acquisition of Covidien made Medtronic the world's largest medical device company by revenues.
=== Computed tomography === Computed tomography angiography has a 98-100% sensitivity and specificity for diagnosing aortic dissections. It is the initial recommended test and also the most commonly used imaging test in the diagnosis of aortic dissections, being utilized in 74-77% of cases in population based studies.
Sources: en.wikipedia.org
In 1999 Rhino Records released the group's first box set, Long Train Runnin': 1970–2000, which featured remastered tunes from the band's entire catalog, a new studio recording of the live concert staple "Little Bitty Pretty One" and an entire disc of previously unreleased studio outtakes and live recordings. And Rhino's release the following year, Sibling Rivalry, was the band's first new studio album since 1991. The material reflected contributions from both Knudsen and McFee, ranging from rock to hip-hop, jazz, adult contemporary and country. The album sold poorly, reflecting the declining sales throughout the adult-oriented rock musical scene. On June 22, 2001, while heading to a show at Caesars Tahoe in Lake Tahoe, Hossack suffered multiple fractures in a motorcycle accident on Highway 88 and had to be airlifted to a Sacramento-area hospital, where he underwent surgery. Drummer and percussionist M. B. Gordy was recruited to fill in for Hossack. After being sidelined for months, Hossack returned to the band in mid-2002. Gordy remained with the band as an auxiliary percussionist until 2005. Saxophonist Ed Wynne filled in for Marc Russo on the Doobies' 2002 summer tour. On October 26, 2004, the Doobie Brothers released Live at Wolf Trap, a live album recorded at Wolf Trap National Park for the Performing Arts in Vienna, Virginia on July 25 of that year. The album features the final recordings of drummer and vocalist Keith Knudsen, who died in February 2005. Ed Toth, from the band Vertical Horizon, took over for Knudsen.
Paracetamol, or acetaminophen, is an analgesic and antipyretic agent used to treat fever and mild to moderate pain. It is a widely available over-the-counter drug sold generically or under various brand names, including Tylenol and Panadol. Paracetamol relieves pain in acute mild migraine and episodic tension headaches. At a standard dose, paracetamol slightly reduces fever, though it is inferior to ibuprofen in that respect: the benefits of its use for fever are unclear, particularly in the context of fever of viral origins. Paracetamol is effective for pain after wisdom tooth extraction, but it is less effective than ibuprofen. The combination of paracetamol and ibuprofen provides greater analgesic efficacy than either drug alone. The pain relief paracetamol provides in osteoarthritis is small and clinically insignificant. Evidence supporting its use in low back pain, cancer pain, and neuropathic pain is insufficient. Paracetamol is the first-line treatment for pain and fever in pregnancy; no causal association with neurodevelopmental disorders has been established, while untreated pain and fever can harm the mother and fetus. At a recommended maximum daily dose for an adult of three to four grams, paracetamol is safe and effective in the short term when used as directed, with uncommon adverse effects similar to those of ibuprofen. It is often used in patients who cannot tolerate nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.
Christine Todd Whitman, administrator of the EPA in the attacks' aftermath, was criticized by U.S. District Judge Deborah Batts, who wrote that Whitman's assurances about air quality were "without question conscience-shocking." Mayor Giuliani was criticized for urging financial industry personnel to return quickly to the greater Wall Street area. The James L. Zadroga 9/11 Health and Compensation Act (2010) allocated $4.2 billion to create the World Trade Center Health Program, which provides testing and treatment for people with long-term health problems related to the 9/11 attacks. The WTC Health Program replaced preexisting 9/11-related health programs such as the Medical Monitoring and Treatment Program and the WTC Environmental Health Center program. In 2020, the NYPD confirmed that 247 NYPD police officers had died due to 9/11-related illnesses. In September 2022, the FDNY confirmed that 299 firefighters had died due to 9/11-related illnesses. Both agencies believe that the death toll will rise dramatically in the coming years. The Port Authority of New York and New Jersey Police Department (PAPD), the law enforcement agency with jurisdiction over the World Trade Center, confirmed that four of its police officers have died of 9/11-related illnesses.
Sources: en.wikipedia.org
In 2001, the LRP-I was merged with the MCW to create the consolidated Meal, Cold Weather/Food Packet, Long Range Patrol (MCW/LRP) ration. As in years past, this was done in order to further standardize supply and save costs, as both were considered compact, high-energy meals that were designed for use by active soldiers in the field. The meal weighs 1 pound (454 g) and comes in 12 different entrees. The meals differ only in the accessory packs. One is geared for use by light infantry and commando units operating in temperate or hot climates and comes in brown or tan packaging. The other is geared more for use in cold weather or high elevations and comes in white packaging.
At the time of the Miller–Urey experiment, Harold Urey was a Professor of Chemistry at the University of Chicago who had a well-renowned career, including receiving the Nobel Prize in Chemistry in 1934 for his isolation of deuterium and leading efforts to use gaseous diffusion for uranium isotope enrichment in support of the Manhattan Project. In 1952, Urey postulated that the high temperatures and energies associated with large impacts in Earth's early history would have provided an atmosphere of methane (CH4), water (H2O), ammonia (NH3), and hydrogen (H2), creating the reducing environment necessary for the Oparin-Haldane "primordial soup" scenario. Stanley Miller arrived at the University of Chicago in 1951 to pursue a PhD under nuclear physicist Edward Teller, another prominent figure in the Manhattan Project. Miller began to work on how different chemical elements were formed in the early universe, but, after a year of minimal progress, Teller was to leave for California to establish Lawrence Livermore National Laboratory and further nuclear weapons research. Miller, having seen Urey lecture on his 1952 paper, approached him about the possibility of a prebiotic synthesis experiment. While Urey initially discouraged Miller, he agreed to allow Miller to try for a year. By February 1953, Miller had mailed a manuscript as sole author reporting the results of his experiment to Science.
This is interpreted by some researchers to mean that although the incorporation of lactobacillic acid into the cell membrane has no significant influence on the physical properties of the membrane, it does change its chemical properties, which is an advantage for the organism. One example of a beneficial effect of lactobacillic acid is provided by Oenococcus oeni. The lactic acid bacterium is used in wine production to convert malic acid into lactic acid during malolactic fermentation into lactic acid, which in turn is converted into ethanol by baker's yeast. In this way, the acidity of the wine is reduced. In the process, Oenococcus oeni is exposed to relatively high concentrations of ethanol produced by yeasts during alcoholic fermentation. Studies of the cell membrane of the bacterium have shown that the biosynthesis rate of phospholidides is increased with increasing ethanol concentration in the surrounding culture medium. In addition, more lactobacillic acid is formed in the membrane lipids, while the content of cis vaccenic acid decreases. This is interpreted as a protective mechanism against the toxic effects of ethanol. The formation of lactobacillic acid helps the bacterium to adapt to unfavorable environmental conditions. A similar protective effect was discovered in L. delbrueckii subsp. bulgaricus. It shows improved survivability against freeze-drying when more lactobacillic acid is present in the cell membrane.
Sources: en.wikipedia.org
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.
Assay calibration and antibody specificity differ between platforms, so identical samples can yield different numbers. A method change within one laboratory can shift results without any biological change. Cross-validation is often needed for multi-site work.
They capture only one moment in a pulsatile pattern and are strongly influenced by recent activity and meals. Repeated sampling or overnight profiles provide a more representative view. Provocative testing is an alternative when a dynamic response is of interest.
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.